Raymond James & Associates’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $473K | Buy |
66,842
+29,865
| +81% | +$211K | ﹤0.01% | 3133 |
|
|
2024
Q2 | $241K | Buy |
36,977
+10,700
| +41% | +$69.8K | ﹤0.01% | 3469 |
|
|
2024
Q1 | $218K | Buy |
26,277
+7,871
| +43% | +$65.3K | ﹤0.01% | 3542 |
|
|
2023
Q4 | $203K | Sell |
18,406
-2,399
| -12% | -$26.4K | ﹤0.01% | 3490 |
|
|
2023
Q3 | $175K | Sell |
20,805
-14,803
| -42% | -$124K | ﹤0.01% | 3470 |
|
|
2023
Q2 | $447K | Buy |
+35,608
| New | +$447K | ﹤0.01% | 2986 |
|